William Blair analysts have raised their projected earnings for Starbucks in fiscal year 2026. The new estimate of $2.37 per share underscores a positive outlook for the coffee company’s financial performance.

William Blair has lowered its third-quarter 2025 earnings forecast for Jasper Therapeutics to a loss of $0.75 per share, according to an analyst note issued on August 14. The deeper-than-expected projection, reported by Defenseworld.net, signals mounting challenges for the California-based biotech firm.